Wiki-Pi
Answer Survey
Home
About
Help
Advanced Search
BTC
Gene Name
betacellulin
Image
Gene Ontology Annotations
Cellular Component
Extracellular Region
Extracellular Space
Plasma Membrane
Integral Component Of Membrane
Molecular Function
Epidermal Growth Factor Receptor Binding
Protein Binding
Growth Factor Activity
Biological Process
Epidermal Growth Factor Receptor Signaling Pathway
Positive Regulation Of Cell Proliferation
Fibroblast Growth Factor Receptor Signaling Pathway
Positive Regulation Of Urine Volume
Fc-epsilon Receptor Signaling Pathway
Negative Regulation Of Apoptotic Process
Innate Immune Response
Positive Regulation Of Cell Differentiation
Positive Regulation Of Mitotic Nuclear Division
Neurotrophin TRK Receptor Signaling Pathway
Phosphatidylinositol-mediated Signaling
Positive Regulation Of Fibroblast Proliferation
Pathways
Signaling by the B Cell Receptor (BCR)
Signaling by FGFR in disease
PIP3 activates AKT signaling
Signaling by EGFRvIII in Cancer
Signaling by SCF-KIT
SHC1 events in ERBB2 signaling
Downstream signaling events of B Cell Receptor (BCR)
DAP12 signaling
PI3K/AKT activation
GRB2 events in ERBB2 signaling
PI-3K cascade
PI3K events in ERBB2 signaling
Downstream signaling of activated FGFR
Innate Immune System
Signaling by PDGF
Signalling by NGF
DAP12 interactions
GAB1 signalosome
Signaling by Ligand-Responsive EGFR Variants in Cancer
NGF signalling via TRKA from the plasma membrane
Signaling by ERBB4
Signaling by Overexpressed Wild-Type EGFR in Cancer
Role of LAT2/NTAL/LAB on calcium mobilization
Constitutive PI3K/AKT Signaling in Cancer
PI3K events in ERBB4 signaling
Signaling by FGFR
Signaling by ERBB2
Signaling by EGFR
Nuclear signaling by ERBB4
SHC1 events in ERBB4 signaling
Downstream signal transduction
Fc epsilon receptor (FCERI) signaling
Signaling by EGFR in Cancer
PI3K/AKT Signaling in Cancer
Adaptive Immune System
Drugs
Diseases
GWAS
Protein-protein Interactions
6 interactors:
EGFR
ERBB2
ERBB4
GMPPA
KRT31
MMP9
Entrez ID
685
HPRD ID
02643
Ensembl ID
Uniprot IDs
P35070
PDB IDs
1IOX
1IP0
Enriched GO Terms of Interacting Partners
?
Phosphatidylinositol-mediated Signaling
Epidermal Growth Factor Receptor Signaling Pathway
ERBB Signaling Pathway
Fibroblast Growth Factor Receptor Signaling Pathway
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway
Cellular Response To Fibroblast Growth Factor Stimulus
Regulation Of ERK1 And ERK2 Cascade
Response To Fibroblast Growth Factor
Protein Autophosphorylation
Neurotrophin TRK Receptor Signaling Pathway
Neurotrophin Signaling Pathway
Fc-epsilon Receptor Signaling Pathway
Enzyme Linked Receptor Protein Signaling Pathway
Fc Receptor Signaling Pathway
Peptidyl-tyrosine Phosphorylation
Signal Transduction By Phosphorylation
Peptidyl-amino Acid Modification
Neuron Differentiation
Immune Response-regulating Cell Surface Receptor Signaling Pathway
Axon Guidance
Locomotion
Positive Regulation Of MAPK Cascade
Immune Response-regulating Signaling Pathway
Positive Regulation Of Kinase Activity
Axonogenesis
Movement Of Cell Or Subcellular Component
Positive Regulation Of Protein Import Into Nucleus
Positive Regulation Of Transferase Activity
Generation Of Neurons
Alkanesulfonate Metabolic Process
Cardiac Muscle Tissue Regeneration
Axon Development
Cellular Response To Growth Factor Stimulus
Cell Morphogenesis Involved In Neuron Differentiation
Regulation Of Cell Migration
Chemotaxis
Response To Growth Factor
Positive Regulation Of Protein Localization To Nucleus
Positive Regulation Of Nucleocytoplasmic Transport
Neurogenesis
Regulation Of MAPK Cascade
Regulation Of Cell Motility
Neuron Projection Morphogenesis
Tissue Development
Positive Regulation Of ERK1 And ERK2 Cascade
Regulation Of Locomotion
Cell Development
Regulation Of Cellular Component Movement
Central Nervous System Morphogenesis
Activation Of Phospholipase A2 Activity By Calcium-mediated Signaling
Tagcloud
?
1000mg
100mg
300mg
aes
already
arm
biliary
btcs
centers
endpoint
endpoints
favored
gemcitabine
infused
intravenously
italy
m2
monotherapy
multicenter
nct00753675
orr
pfs
placebo
plus
reporting
tolerability
v
vandetanib
worsening